Technical brief describes and compares four core management strategies to reduce psychiatric readmissions—length of stay for inpatient care, transition support services, short-term alternatives to psychiatric rehospitalization, and long-term approaches for reducing psychiatric rehospitalization—for patients at high risk of psychiatric readmission.

The guideline describes the critical decision points in the management of Major Depressive Disorder (MDD) and provides clear and comprehensive evidence based recommendations incorporating current information and practices for practitioners throughout the DoD and VA Health Care systems.

An information series that provides clinicians with information related to alcohol.

With this Guide, the National Institute on Alcohol Abuse and Alcoholism introduces a simple, quick, empirically derived tool for identifying youth at risk for alcohol-related problems.

The AHRQ academy, which is a national resource for integrating behavioral health and primary care, offers guidance on how to integrate behavioral health and medication-assisted treatment for opioid use disorder into primary care or other ambulatory care settings to improve healthcare delivery and to achieve better patient outcomes.

This AHRQ environmental scan lists tools and resources for the implementation of medication-assisted treatment (MAT) in a wide variety of settings.

This Technical Brief describes promising and innovative medication-assisted treatment (MAT) models of care in primary care settings, describe barriers to MAT implementation, summarize the evidence available on MAT models of care in primary care settings, identifies gaps in the evidence base, and guides future research.

The objective of this review is to compare the benefits and harms of second-generation antidepressants (SGAs), psychological, complementary and alternative medicine, and exercise treatment options as first-step interventions for adult outpatients with acute-phase major depressive disorder (MDD), and as second-step interventions for patients with MDD who did not achieve remission after a first treatment attempt with SGAs.

Systematic evidence review and meta-analysis of the efficacy, comparative effectiveness, and harms of medications both FDA approved and others for adults with alcohol-use disorders, and to evaluate the evidence from primary care settings.

This is a summary of a systematic review evaluating the evidence regarding the efficacy, comparative effectiveness, and adverse effects of medications in adults with Alcohol Use Disorder.

The purpose of this systematic review is to evaluate treatments for adults with schizophrenia.

Systematic evidence review comparing the effectiveness of strategies to prevent and de-escalate aggressive behaviors in psychiatric patients in acute care settings, including interventions aimed specifically at reducing use of seclusion and restraint.

Systematic evidence review assessing psychosocial and pharmacologic treatment for children with disruptive behavior disorders.

This systematic literature review addresses questions about the comparative effectiveness of smoking cessation treatments for patients with depression

Systematic evidence review examining comparative effectiveness and harms of psychotherapy and medications for childhood anxiety disorders panic disorder, social anxiety disorder, specific phobias, generalized anxiety disorder, and separation anxiety.

The purpose of this systematic review is to determine optimal doses, routes of administration, and dosing strategies of naloxone for suspected opioid overdose in out-of-hospital settings, and whether transport to a hospital following successful opioid overdose reversal with naloxone is necessary.

Developed by AHRQ, this report reviews the scientific and grey literature about implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care settings.

This toolkit supports a structured, team-based approach to improving the management of patients who take opioids to ease chronic pain.